Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Biolase, Inc. (NASDAQ: BIOL).

Full DD Report for BIOL

You must become a subscriber to view this report.


Recent News from (NASDAQ: BIOL)

Biolase (BIOL) Presents at Rodman & Renshaw.C. Wainwright 20th Annual Global Investment Conference - Slideshow
The following slide deck was published by Biolase, Inc. in conjunction with this Read more ...
Source: SeekingAlpha
Date: September, 06 2018 15:22
BIOLASE Announces Participation At The 20th Annual Global Investment Conference In New York City September 4-6, 2018
IRVINE, Calif. , Aug. 22, 2018 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced it will be featured as a presenting company at the 20 th Annual Rodman & Renshaw Global Investment Conference, sponsored by H.C. Wainwright & Co., LLC....
Source: PR Newswire
Date: August, 22 2018 08:30
BIOLASE Hosts Pediatric Dental Laser Training With Healthy Smiles For Kids of Orange County for University of Southern California Pediatric Dentistry Clinicians
IRVINE, Calif. , Aug. 22, 2018 /PRNewswire/ --   BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, and Healthy Smiles For Kids of Orange County , a leading nonprofit organization that is improving the oral health of local children, recently held an educational tr...
Source: PR Newswire
Date: August, 22 2018 08:00
BIOLASE Employee Volunteers Visit Over 650 Local Dental Offices to Increase Awareness of Laser Dentistry
LOS ANGELES and IRVINE, Calif. , Aug. 14, 2018 /PRNewswire/ --  BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, and its employees recently launched a dental laser awareness campaign where BIOLASE employees volunteer to visit local dentists in Los Angeles and O...
Source: PR Newswire
Date: August, 14 2018 08:00
Biolase, Inc. (BIOL) CEO Todd Norbe on Q2 2018 Results - Earnings Call Transcript
Biolase, Inc. (BIOL) Q2 2018 Earnings Conference Call August 8, 2018 16:30 PM ET Executives Rene Caron - DresnerAllenCaron Investor Relations Todd Norbe - President and Chief Executive Officer John Beaver - Executive Vice President and Chief Financial Officer Analysts Ed Wo...
Source: SeekingAlpha
Date: August, 08 2018 22:20
BIOLASE names Todd A. Norbe President and CEO
BIOLASE (NASDAQ: BIOL ) names Todd A. Norbe as President and CEO. Also, Senior VP and CFO John R. Beaver, serving as Interim CEO, has been promoted to Executive VP and CFO. More news on: Biolase, Inc., Healthcare stocks news, Read more ...
Source: SeekingAlpha
Date: August, 08 2018 08:52
BIOLASE Reports 2018 Second Quarter Results
IRVINE, Calif. , Aug. 8, 2018 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ:BIOL), the global leader in dental lasers, today reported its financial results for its second quarter and six months ended June 30, 2018 . Worldwide net revenue for the 2018 second quarter was $12.2 mill...
Source: PR Newswire
Date: August, 08 2018 08:30
BIOLASE Names Todd A. Norbe President, Chief Executive Officer
IRVINE, Calif. , Aug. 8, 2018 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers announced today that it has named Todd A. Norbe , a veteran dental industry executive and a member of the Company's Board of Directors, as President and Chief Executive Officer....
Source: PR Newswire
Date: August, 08 2018 08:00
BIOLASE® to Host 2018 Second Quarter Financial Results Conference Call on August 8, 2018
BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that the Company will host a conference call on Wednesday, August 8, 2018, at 4:30 p.m. Eastern Time to discuss its operating results for the second quarter ended June 30, 2018, and to answer questions. A press...
Source: Business Wire
Date: August, 01 2018 08:30
BIOLASE and the Los Angeles Angels Announce 2018 Baseball Season Partnership
LOS ANGELES and IRVINE, Calif , July 26, 2018 /PRNewswire/ --  BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, and the Los Angeles Angels today announced a sponsorship agreement to educate the public about the benefits of dental lasers during the 2018 baseball ...
Source: PR Newswire
Date: July, 26 2018 08:00

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-071.131.131.171.1224,248
2018-12-061.141.171.1721.1248,176
2018-12-051.191.191.191.130123,383
2018-12-041.191.13751.191.130123,071
2018-12-031.151.181.181.1515,808

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-077,27015,83245.9197Short
2018-12-061,21011,16410.8384Cover
2018-12-042,2005,75638.2210Short
2018-12-034,6317,05465.6507Short
2018-11-306,63825,15926.3842Cover

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on BIOL.


About Biolase, Inc. (NASDAQ: BIOL)

Logo for Biolase, Inc. (NASDAQ: BIOL)

Not available

 

Contact Information

 

 

Current Management

  • Jeffrey W. Jones / President, CEO
  • Stephen R. Tartamella / CFO

Current Share Structure

  • Issue and Outstanding: 20,476,048 - 05/11/2018

 


Recent Filings from (NASDAQ: BIOL)

Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 11 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 10 2018
Securities offered to employees under employee benefit plans
Filing Type: S-8Filing Source: edgar
Filing Date: May, 10 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 04 2018
Amendment to a previously filed 8-K
Filing Type: 8-K/AFiling Source: edgar
Filing Date: May, 03 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 02 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 13 2018
Additional proxy soliciting materials - definitive
Filing Type: DEFA14AFiling Source: edgar
Filing Date: April, 13 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 10 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: April, 05 2018

 

 


Daily Technical Chart for (NASDAQ: BIOL)

Daily Technical Chart for (NASDAQ: BIOL)


Stay tuned for daily updates and more on (NASDAQ: BIOL)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: BIOL)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in BIOL is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of BIOL and does not buy, sell, or trade any shares of BIOL. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/